{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:12:35Z","timestamp":1779354755490,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guizhou Science and Technology Project","award":["Basic-ZK[2024] General 400"],"award-info":[{"award-number":["Basic-ZK[2024] General 400"]}]},{"name":"Guizhou Science and Technology Project","award":["Basic-ZK[2023] General 437"],"award-info":[{"award-number":["Basic-ZK[2023] General 437"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15978-4","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T07:57:07Z","timestamp":1775894227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomics and proteomics analyses reveal the potiental mechanisms underlying colorectal cancer and chemotherapy targets"],"prefix":"10.1186","volume":"26","author":[{"given":"Qianqian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianbao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"3","key":"15978_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"15978_CR2","first-page":"409","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409\u201336.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"15978_CR3","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"15978_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","volume":"7","author":"SG Patel","year":"2022","unstructured":"Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022;7(3):262\u201374.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"15978_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.soc.2021.12.001","volume":"31","author":"NN Mahmoud","year":"2022","unstructured":"Mahmoud NN. Colorectal Cancer: Preoperative Evaluation and Staging. Surg Oncol Clin N Am. 2022;31(2):127\u201341.","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"15978_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41420-025-02745-w","volume":"11","author":"GS Sica","year":"2025","unstructured":"Sica GS, Bischof J, Funke L, Hartmut J, Candi E, Mauriello A, et al. Evidence of fructose metabolism in colorectal cancer. Cell Death Discov. 2025;11(1):464.","journal-title":"Cell Death Discov"},{"key":"15978_CR7","doi-asserted-by":"publisher","first-page":"1653442","DOI":"10.3389\/fimmu.2025.1653442","volume":"16","author":"Z Ma","year":"2025","unstructured":"Ma Z, Wang S, Liu S, Yang W, Hu J, Lv L, et al. Metabolic syndrome in colorectal cancer liver metastasis: metabolic reprogramming and microenvironment crosstalk. Front Immunol. 2025;16:1653442.","journal-title":"Front Immunol"},{"key":"15978_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cancers17213438","volume":"17","author":"M Capuozzo","year":"2025","unstructured":"Capuozzo M, Picone C, Sabbatino F, Santorsola M, Caraglia F, Iervolino D, et al. Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal Cancers. Cancers (Basel). 2025;17:21.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"15978_CR9","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1002\/1878-0261.13791","volume":"19","author":"Z Hu","year":"2025","unstructured":"Hu Z, Shen F, Liu Y, Zhong Z, Chen Y, Xia Z, et al. Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol. 2025;19(6):1737\u201350.","journal-title":"Mol Oncol"},{"key":"15978_CR10","doi-asserted-by":"publisher","first-page":"6858809","DOI":"10.1155\/2021\/6858809","volume":"2021","author":"C Zhang","year":"2021","unstructured":"Zhang C, Zhou S, Chang H, Zhuang F, Shi Y, Chang L, et al. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer. Dis Markers. 2021;2021:6858809.","journal-title":"Dis Markers"},{"issue":"5","key":"15978_CR11","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1053\/j.gastro.2014.01.017","volume":"146","author":"SK Manna","year":"2014","unstructured":"Manna SK, Tanaka N, Krausz KW, Haznadar M, Xue X, Matsubara T, et al. Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans. Gastroenterology. 2014;146(5):1313\u201324.","journal-title":"Gastroenterology"},{"issue":"1","key":"15978_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00726-025-03448-3","volume":"57","author":"A Ramzy","year":"2025","unstructured":"Ramzy A, Abdelmoneim TK, Arafat M, Mokhtar M, Bakkar A, Mokhtar A, et al. Metabolomic analysis reveals key changes in amino acid metabolism in colorectal cancer patients. Amino Acids. 2025;57(1):22.","journal-title":"Amino Acids"},{"issue":"6","key":"15978_CR13","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1021\/pr400337b","volume":"12","author":"B Tan","year":"2013","unstructured":"Tan B, Qiu Y, Zou X, Chen T, Xie G, Cheng Y, et al. Metabonomics identifies serum metabolite markers of colorectal cancer. J Proteome Res. 2013;12(6):3000\u20139.","journal-title":"J Proteome Res"},{"issue":"6","key":"15978_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11306-025-02344-x","volume":"21","author":"F Qi","year":"2025","unstructured":"Qi F, Sun Y, Liu J, Liu X, Sun H, Guo Z, et al. Investigating stage-specific metabolic alterations in colorectal cancer through urine metabolomics. Metabolomics. 2025;21(6):152.","journal-title":"Metabolomics"},{"key":"15978_CR15","doi-asserted-by":"publisher","first-page":"789889","DOI":"10.3389\/fmolb.2022.789889","volume":"9","author":"P Cui","year":"2022","unstructured":"Cui P, Li X, Huang C, Li Q, Lin D. Metabolomics and its Applications in Cancer Cachexia. Front Mol Biosci. 2022;9:789889.","journal-title":"Front Mol Biosci"},{"issue":"6928","key":"15978_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature01514","volume":"422","author":"S Hanash","year":"2003","unstructured":"Hanash S. Disease proteomics. Nature. 2003;422(6928):226\u201332.","journal-title":"Nature"},{"issue":"Suppl 1","key":"15978_CR17","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1097\/FTD.0000000000000243","volume":"38","author":"U Christians","year":"2016","unstructured":"Christians U, Klawitter J, Klawitter J. Biomarkers in Transplantation\u2013Proteomics and Metabolomics. Ther Drug Monit. 2016;38(Suppl 1):S70\u20134.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"15978_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/prca.201500083","volume":"10","author":"P Del Boccio","year":"2016","unstructured":"Del Boccio P, Rossi C, di Ioia M, Cicalini I, Sacchetta P, Pieragostino D. Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine. Proteom Clin Appl. 2016;10(4):470\u201384.","journal-title":"Proteom Clin Appl"},{"issue":"1","key":"15978_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/13880209.2022.2040544","volume":"60","author":"S Chen","year":"2022","unstructured":"Chen S, Zhou M, Zhao X, Han Y, Huang Y, Zhang L, et al. Metabolomics coupled with network pharmacology study on the protective effect of Keguan-1 granules in LPS-induced acute lung injury. Pharm Biol. 2022;60(1):525\u201334.","journal-title":"Pharm Biol"},{"key":"15978_CR20","doi-asserted-by":"publisher","first-page":"706907","DOI":"10.3389\/fgene.2021.706907","volume":"12","author":"CH Gao","year":"2021","unstructured":"Gao CH, Yu G, Cai P, ggVennDiagram. An Intuitive, Easy-to-Use, and Highly Customizable R Package to Generate Venn Diagram. Front Genet. 2021;12:706907.","journal-title":"Front Genet"},{"key":"15978_CR21","doi-asserted-by":"publisher","first-page":"103470","DOI":"10.1016\/j.redox.2024.103470","volume":"79","author":"X Qi","year":"2025","unstructured":"Qi X, Wang S, Fang C, Jia J, Lin L, Yuan T. Machine learning and SHAP value interpretation for predicting comorbidity of cardiovascular disease and cancer with dietary antioxidants. Redox Biol. 2025;79:103470.","journal-title":"Redox Biol"},{"key":"15978_CR22","doi-asserted-by":"publisher","first-page":"1665056","DOI":"10.3389\/fonc.2025.1665056","volume":"15","author":"D Wang","year":"2025","unstructured":"Wang D, Zou S, Ding J, Gao C, Wang J, Tang Z. Crosstalk between dysregulated amino acid sensing and glucose and lipid metabolism in colorectal cancer. Front Oncol. 2025;15:1665056.","journal-title":"Front Oncol"},{"key":"15978_CR23","doi-asserted-by":"publisher","first-page":"1565090","DOI":"10.3389\/fonc.2025.1565090","volume":"15","author":"J Yue","year":"2025","unstructured":"Yue J, Fang H, Yang Q, Feng R, Ren G. Integrating multi-omics and machine learning methods reveals the metabolism of amino acids and derivatives-related signature in colorectal cancer. Front Oncol. 2025;15:1565090.","journal-title":"Front Oncol"},{"key":"15978_CR24","first-page":"102157","volume":"43","author":"C Zhang","year":"2025","unstructured":"Zhang C, Rao Z, Zhan X, Qin J, Yang L, Yin Q, et al. Deciphering tryptophan metabolism in colorectal cancer through multi-omics analysis. Biochem Biophys Rep. 2025;43:102157.","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"15978_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.62347\/ZSOO2247","volume":"15","author":"M Zhu","year":"2025","unstructured":"Zhu M, Hu Y, Gu Y, Lin X, Jiang X, Gong C, et al. Role of amino acid metabolism in tumor immune microenvironment of colorectal cancer. Am J Cancer Res. 2025;15(1):233\u201347.","journal-title":"Am J Cancer Res"},{"key":"15978_CR26","doi-asserted-by":"publisher","first-page":"1575829","DOI":"10.3389\/fimmu.2025.1575829","volume":"16","author":"T Sun","year":"2025","unstructured":"Sun T, Chen Y, Chen YX. Single-cell and bulk transcriptome analyses reveal elevated amino acid metabolism promoting tumor-directed immune evasion in colorectal cancer. Front Immunol. 2025;16:1575829.","journal-title":"Front Immunol"},{"key":"15978_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.aninu.2025.04.008","volume":"23","author":"Y Lv","year":"2025","unstructured":"Lv Y, Feng Y, Lu J, Zhang S, Wei Y, Gao C. New insights into methionine\u2019s role in maintaining intestinal stem cell regeneration via autophagy regulation. Anim Nutr. 2025;23:17\u201329.","journal-title":"Anim Nutr"},{"issue":"12","key":"15978_CR28","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s00383-021-04987-y","volume":"37","author":"K Yokota","year":"2021","unstructured":"Yokota K, Hinoki A, Hiramatsu K, Amano H, Kawamura M, Kuwatsuka Y, et al. Urinary N(1),N(12)-diacetylspermine as a biomarker for pediatric cancer: a case-control study. Pediatr Surg Int. 2021;37(12):1659\u201365.","journal-title":"Pediatr Surg Int"},{"issue":"33","key":"15978_CR29","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1200\/JCO.2015.61.7779","volume":"33","author":"WR Wikoff","year":"2015","unstructured":"Wikoff WR, Hanash S, DeFelice B, Miyamoto S, Barnett M, Zhao Y, et al. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B. J Clin Oncol. 2015;33(33):3880\u20136.","journal-title":"J Clin Oncol"},{"issue":"6","key":"15978_CR30","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.21873\/anticanres.12634","volume":"38","author":"MK Ven\u00e4l\u00e4inen","year":"2018","unstructured":"Ven\u00e4l\u00e4inen MK, Roine AN, H\u00e4kkinen MR, Veps\u00e4l\u00e4inen JJ, Kumpulainen PS, Kiviniemi MS, et al. Altered Polyamine Profiles in Colorectal Cancer. Anticancer Res. 2018;38(6):3601\u20137.","journal-title":"Anticancer Res"},{"issue":"1","key":"15978_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-0436.1981.tb01123.x","volume":"19","author":"O Heby","year":"1981","unstructured":"Heby O. Role of polyamines in the control of cell proliferation and differentiation. Differentiation. 1981;19(1):1\u201320.","journal-title":"Differentiation"},{"key":"15978_CR32","doi-asserted-by":"publisher","unstructured":"Kober C, Roewe J, Schmees N, Roese L, Roehn U, Bader B, et al. Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy. J Immunother Cancer. 2023;11(11):e007495. https:\/\/doi.org\/10.1136\/jitc-2023-007495.","DOI":"10.1136\/jitc-2023-007495"},{"issue":"8","key":"15978_CR33","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.21873\/anticanres.17153","volume":"44","author":"Y Yokota","year":"2024","unstructured":"Yokota Y, Nozawa H, Sonoda H, Yokoyama Y, Emoto S, Murono K, et al. Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition. Anticancer Res. 2024;44(8):3337\u201342.","journal-title":"Anticancer Res"},{"issue":"6","key":"15978_CR34","doi-asserted-by":"publisher","first-page":"e70037","DOI":"10.1002\/cai2.70037","volume":"4","author":"Z Cui","year":"2025","unstructured":"Cui Z, Wang D, Zhang Y, Yuan L, Zhang Y, Qi X. Role of Tryptophan Metabolism in Cancer. Cancer Innov. 2025;4(6):e70037.","journal-title":"Cancer Innov"},{"issue":"9","key":"15978_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12032-025-02972-2","volume":"42","author":"NS Kiran","year":"2025","unstructured":"Kiran NS, Yashaswini C, Chatterjee A, Prajapati B. Impact of gastrointestinal dysbiosis on tryptophan metabolism and neurological cancer progression. Med Oncol. 2025;42(9):412.","journal-title":"Med Oncol"},{"issue":"3","key":"15978_CR36","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1039\/D1MO00022E","volume":"17","author":"Y Shen","year":"2021","unstructured":"Shen Y, Sun M, Zhu J, Wei M, Li H, Zhao P, et al. Tissue metabolic profiling reveals major metabolic alteration in colorectal cancer. Mol Omics. 2021;17(3):464\u201371.","journal-title":"Mol Omics"},{"issue":"7","key":"15978_CR37","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/ijc.35286","volume":"156","author":"J Korbecki","year":"2025","unstructured":"Korbecki J, Bosiacki M, Kupnicka P, Barczak K, Zi\u0119tek P, Chlubek D, et al. Choline kinases: Enzymatic activity, involvement in cancer and other diseases, inhibitors. Int J Cancer. 2025;156(7):1314\u201325.","journal-title":"Int J Cancer"},{"issue":"1","key":"15978_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00109-008-0409-0","volume":"87","author":"F Mansilla","year":"2009","unstructured":"Mansilla F, da Costa KA, Wang S, Kruh\u00f8ffer M, Lewin TM, Orntoft TF, et al. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J Mol Med (Berl). 2009;87(1):85\u201397.","journal-title":"J Mol Med (Berl)"},{"issue":"23","key":"15978_CR39","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1158\/0008-5472.CAN-25-0235","volume":"85","author":"J Zhao","year":"2025","unstructured":"Zhao J, Chen B, Deng Y, Fan L, Yin S, Yu H, et al. ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion. Cancer Res. 2025;85(23):4701\u201317.","journal-title":"Cancer Res"},{"issue":"42","key":"15978_CR40","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1038\/s41388-024-03150-w","volume":"43","author":"X Li","year":"2024","unstructured":"Li X, Hu Z, Shi Q, Qiu W, Liu Y, Liu Y, et al. Elevated choline drives KLF5-dominated transcriptional reprogramming to facilitate liver cancer progression. Oncogene. 2024;43(42):3121\u201336.","journal-title":"Oncogene"},{"issue":"1","key":"15978_CR41","doi-asserted-by":"publisher","first-page":"11310","DOI":"10.1038\/s41598-025-96004-8","volume":"15","author":"X Wu","year":"2025","unstructured":"Wu X, Yang Q, Leng L, Yang P, Zhu Z. Altered metabolic profiles in colon and rectal cancer. Sci Rep. 2025;15(1):11310.","journal-title":"Sci Rep"},{"issue":"1","key":"15978_CR42","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1186\/s12967-025-06908-2","volume":"23","author":"MT De Angelis","year":"2025","unstructured":"De Angelis MT, Rizzuto A, Amaddeo A, Sagnelli C, Vono N, Reda M, et al. Distinctive chromosomal, mutational and transcriptional profiling in colon versus rectal cancers. J Transl Med. 2025;23(1):869.","journal-title":"J Transl Med"},{"key":"15978_CR43","doi-asserted-by":"publisher","unstructured":"Kneis B, Wirtz S, Weber K, Denz A, Gittler M, Geppert C, et al. Colon cancer microbiome landscaping: differences in right- and left-sided colon cancer and a tumor microbiome-ileal microbiome association. Int J Mol Sci. 2023;24(4):3265. https:\/\/doi.org\/10.3390\/ijms24043265.","DOI":"10.3390\/ijms24043265"},{"issue":"2","key":"15978_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF00227535","volume":"162","author":"DA Dueck","year":"1996","unstructured":"Dueck DA, Chan M, Tran K, Wong JT, Jay FT, Littman C, et al. The modulation of choline phosphoglyceride metabolism in human colon cancer. Mol Cell Biochem. 1996;162(2):97\u2013103.","journal-title":"Mol Cell Biochem"},{"key":"15978_CR45","doi-asserted-by":"publisher","first-page":"104910","DOI":"10.1016\/j.critrevonc.2025.104910","volume":"214","author":"PV Nuzzo","year":"2025","unstructured":"Nuzzo PV, Rodrigues S, Ribeiro CF, Teixeira IF, Fanelli GN, Bleve S, et al. Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors. Crit Rev Oncol Hematol. 2025;214:104910.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"15978_CR46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1194\/jlr.M007575","volume":"52","author":"SS Prasad","year":"2011","unstructured":"Prasad SS, Garg A, Agarwal AK. Enzymatic activities of the human AGPAT isoform 3 and isoform 5: localization of AGPAT5 to mitochondria. J Lipid Res. 2011;52(3):451\u201362.","journal-title":"J Lipid Res"},{"issue":"4","key":"15978_CR47","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10863-024-10028-9","volume":"56","author":"M Takai","year":"2024","unstructured":"Takai M, Mori S, Honoki K, Tsujiuchi T. Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cancer cell biology. J Bioenerg Biomembr. 2024;56(4):475\u201382.","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"15978_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41392-020-0117-y","volume":"5","author":"D Zhang","year":"2020","unstructured":"Zhang D, Shi R, Xiang W, Kang X, Tang B, Li C, et al. The Agpat4\/LPA axis in colorectal cancer cells regulates antitumor responses via p38\/p65 signaling in macrophages. Signal Transduct Target Ther. 2020;5(1):24.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"15978_CR49","first-page":"140","volume":"4","author":"C Abbenhardt","year":"2013","unstructured":"Abbenhardt C, Poole EM, Kulmacz RJ, Xiao L, Curtin K, Galbraith RL, et al. Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. Int J Mol Epidemiol Genet. 2013;4(3):140\u20139.","journal-title":"Int J Mol Epidemiol Genet"},{"issue":"4","key":"15978_CR50","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/jat.1411","volume":"29","author":"R Matuo","year":"2009","unstructured":"Matuo R, Sousa FG, Escargueil AE, Grivicich I, Garcia-Santos D, Chies JA, et al. 5-Fluorouracil and its active metabolite FdUMP cause DNA damage in human SW620 colon adenocarcinoma cell line. J Appl Toxicol. 2009;29(4):308\u201316.","journal-title":"J Appl Toxicol"},{"key":"15978_CR51","doi-asserted-by":"publisher","first-page":"1532695","DOI":"10.3389\/fphar.2024.1532695","volume":"15","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Zhang Y, Liu J, Chen P, Onga A, Cho N, et al. Polydatin enhances oxaliplatin-induced cell death by activating NOX5-ROS-mediated DNA damage and ER stress in colon cancer cells. Front Pharmacol. 2024;15:1532695.","journal-title":"Front Pharmacol"},{"key":"15978_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/cancers13246165","volume":"13","author":"L Shimolina","year":"2021","unstructured":"Shimolina L, Gulin A, Ignatova N, Druzhkova I, Gubina M, Lukina M, et al. The Role of Plasma Membrane Viscosity in the Response and Resistance of Cancer Cells to Oxaliplatin. Cancers (Basel). 2021;13:24.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"15978_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41538-024-00318-2","volume":"8","author":"XH Huang","year":"2024","unstructured":"Huang XH, Huang CY. Fructose shields human colorectal cancer cells from hypoxia-induced necroptosis. NPJ Sci Food. 2024;8(1):71.","journal-title":"NPJ Sci Food"},{"issue":"2","key":"15978_CR54","doi-asserted-by":"publisher","first-page":"119878","DOI":"10.1016\/j.bbamcr.2024.119878","volume":"1872","author":"AVL Marques","year":"2025","unstructured":"Marques AVL, Ruginsk BE, Prado LO, de Lima DE, Daniel IW, Moure VR, et al. The association of ABC proteins with multidrug resistance in cancer. Biochim Biophys Acta Mol Cell Res. 2025;1872(2):119878.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"15978_CR55","doi-asserted-by":"publisher","unstructured":"Aquilani R, Brugnatelli S, Maestri R, Iadarola P, Corallo S, Pagani, A et al. Chemotherapy-induced changes in plasma amino acids and lipid oxidation of resected patients with colorectal cancer: a background for future studies. Int J Mol Sci. 2024;25(10):5300. https:\/\/doi.org\/10.3390\/ijms25105300.","DOI":"10.3390\/ijms25105300"},{"key":"15978_CR56","doi-asserted-by":"publisher","unstructured":"Bastings J, van Eijk HM, Olde Damink SW, Rensen SS. d-amino acids in health and disease: a focus on cancer. Nutrients. 2019;11(9):2205. https:\/\/doi.org\/10.3390\/nu11092205.","DOI":"10.3390\/nu11092205"},{"issue":"1","key":"15978_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ol.2017.6161","volume":"14","author":"W Zhu","year":"2017","unstructured":"Zhu W, Li GX, Chen HL, Liu XY. The role of eukaryotic translation initiation factor 6 in tumors. Oncol Lett. 2017;14(1):3\u20139.","journal-title":"Oncol Lett"},{"issue":"7","key":"15978_CR58","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1166\/jbn.2019.2792","volume":"15","author":"J Lin","year":"2019","unstructured":"Lin J, Yu X, Xie L, Wang P, Li T, Xiao Y, et al. eIF6 Promotes Colorectal Cancer Proliferation and Invasion by Regulating AKT-Related Signaling Pathways. J Biomed Nanotechnol. 2019;15(7):1556\u201367.","journal-title":"J Biomed Nanotechnol"},{"issue":"1","key":"15978_CR59","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ymthe.2021.08.026","volume":"30","author":"Y Li","year":"2022","unstructured":"Li Y, Wang Z, Su P, Liang Y, Li Z, Zhang H, et al. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt\/beta-catenin pathway. Mol Ther. 2022;30(1):415\u201330.","journal-title":"Mol Ther"},{"key":"15978_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-031-14740-1_1","volume":"101","author":"A Bracher","year":"2023","unstructured":"Bracher A, Verghese J. Nucleotide Exchange Factors for Hsp70 Molecular Chaperones: GrpE, Hsp110\/Grp170, HspBP1\/Sil1, and BAG Domain Proteins. Subcell Biochem. 2023;101:1\u201339.","journal-title":"Subcell Biochem"},{"issue":"1","key":"15978_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1134\/S1607672923700631","volume":"515","author":"EA Romanova","year":"2024","unstructured":"Romanova EA, Yurkina DM, Yashin DV, Sashchenko LP, Georgiev GP. HspBP1 in Complex with the Peptide of the Innate Immunity Protein Tag7 is Able to Lyse Tumor Cells Carrying TNFR1 Receptor. Dokl Biochem Biophys. 2024;515(1):36\u201340.","journal-title":"Dokl Biochem Biophys"},{"key":"15978_CR62","doi-asserted-by":"publisher","first-page":"1627114","DOI":"10.3389\/fphar.2025.1627114","volume":"16","author":"J Ma","year":"2025","unstructured":"Ma J, Zhang M, Mulati S, Nabi X, Zhang W. Esculetin inhibits the PI3K\/Akt\/mTOR pathway and enhances anti-colorectal cancer activity via binding to ENO1. Front Pharmacol. 2025;16:1627114.","journal-title":"Front Pharmacol"},{"issue":"4","key":"15978_CR63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3892\/etm.2024.12415","volume":"27","author":"Y Liu","year":"2024","unstructured":"Liu Y, Hou Y, Zhang F, Wang X. ENO1 deletion potentiates ferroptosis and decreases glycolysis in colorectal cancer cells via AKT\/STAT3 signaling. Exp Ther Med. 2024;27(4):127.","journal-title":"Exp Ther Med"},{"issue":"1","key":"15978_CR64","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-022-01578-w","volume":"21","author":"K Yuan","year":"2022","unstructured":"Yuan K, Lan J, Xu L, Feng X, Liao H, Xie K, et al. Long noncoding RNA TLNC1 promotes the growth and metastasis of liver cancer via inhibition of p53 signaling. Mol Cancer. 2022;21(1):105.","journal-title":"Mol Cancer"},{"issue":"4","key":"15978_CR65","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1080\/15548627.2020.1741318","volume":"17","author":"FRP Dewi","year":"2021","unstructured":"Dewi FRP, Jiapaer S, Kobayashi A, Hazawa M, Ikliptikawati DK, Hartono, et al. Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma. Autophagy. 2021;17(4):1001\u201312.","journal-title":"Autophagy"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15978-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:04:11Z","timestamp":1779354251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15978-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15978"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15978-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was in accordance with the Declaration of Helsinki. The study protocol was reviewed and sanctioned by the Ethics Committee of the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine (Number: KS2022-04). Informed consent to participate was obtained from all of the participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"656"}}